Severity, timeline, and management of complications after stereotactic brain biopsy
| Autor: | Bertrand Mathon, Franck Bielle, Chung-Hi Do, Ahmed Idbaih, Vincent Degos, Eimad Shotar, Mehdi Touat, Karima Mokhtari, R. Pasqualotto, Aymeric Amelot, Alexandre Carpentier, Marc Pineton de Chambrun, Mamadou Deme, Lydia Chougar, Alexandre Le Joncour, Pauline Marijon, Alice Jacquens, Maximilien Riche |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Adult
medicine.medical_specialty Stereotactic biopsy Biopsy Asymptomatic law.invention Stereotaxic Techniques law medicine Humans Adverse effect Aged Retrospective Studies medicine.diagnostic_test Brain Neoplasms business.industry Brain biopsy Brain Reproducibility of Results General Medicine Intensive care unit Surgery Stereotaxy medicine.symptom business Complication |
| Zdroj: | Journal of Neurosurgery. 136:867-876 |
| ISSN: | 1933-0693 0022-3085 |
| DOI: | 10.3171/2021.3.jns21134 |
| Popis: | OBJECTIVE The literature shows discrepancies in stereotactic brain biopsy complication rates, severities, and outcomes. Little is known about the timeline of postbiopsy complications. This study aimed to analyze 1) complications following brain biopsies, using a graded severity scale, and 2) a timeline of complication occurrence. The secondary objectives were to determine factors associated with an increased risk of complications and to assess complication-related management and extra costs. METHODS The authors retrospectively examined 1500 consecutive stereotactic brain biopsies performed in adult patients at their tertiary medical center between April 2009 and April 2019. RESULTS Three hundred eighty-one biopsies (25.4%) were followed by a complication, including 88.2% of asymptomatic hemorrhages. Symptomatic complications involved 3.0% of the biopsies, and 0.8% of the biopsies were fatal. The severity grading scale had a 97.6% interobserver reproducibility. Twenty-three (51.1%) of the 45 symptomatic complications occurred within the 1st hour following the biopsy, while 75.6% occurred within the first 6 hours. Age ≥ 65 years, second biopsy procedures, gadolinium-enhanced lesions, glioblastomas, and lymphomas were predictors of biopsy-related complications. Brainstem biopsy-targeted lesions and cerebral toxoplasmosis were predictive of mortality. Asymptomatic hemorrhage was associated with delayed (> 6 hours) symptomatic complications. Symptomatic complications led to extended hospitalization in 86.7% of patients. The average extra cost for management of a patient with postbiopsy symptomatic complication was $35,702. CONCLUSIONS Symptomatic complications from brain biopsies are infrequent but associated with substantial adverse effects and cost implications for the healthcare system. The use of a severity grading scale, as the authors propose in this article, helps to classify complications according to the therapeutic consequences and the patient’s outcome. Because this study indicates that most complications occur within the first few hours following the biopsy, postbiopsy monitoring can be tailored accordingly. The authors therefore recommend systematic monitoring for 2 hours in the recovery unit and a CT scan 2 hours after the end of the biopsy procedure. In addition, they propose a modern algorithm for optimal postoperative management of patients undergoing stereotactic biopsy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|